title: Key concepts and critical issues on epoetin and filgrastim biosimilars. A position paper from the Italian Society of Hematology, Italian Society of Experimental Hematology, and Italian Group for Bone Marrow Transplantation.
authors: Laboratory of Clinical Epidemiology and Center for the Study of Myelofibrosis, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy.
authors: Giovanni
authors: G
authors: Barosi
authors: Alberto
authors: A
authors: Bosi
authors: Maria P
authors: MP
authors: Abbracchio
authors: Romano
authors: R
authors: Danesi
authors: Armando
authors: A
authors: Genazzani
authors: Paolo
authors: P
authors: Corradini
authors: Fabrizio
authors: F
authors: Pane
authors: Sante
authors: S
authors: Tura
mesh_terms: D006801:Humans; D000740:Anemia / Q000188:drug therapy; D017277:Drug Approval / Q000331:legislation & jurisprudence; D004921:Erythropoietin / Q000627:therapeutic use; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D007558:Italy; D009369:Neoplasms / Q000188:drug therapy; D009503:Neutropenia / Q000188:drug therapy; D011994:Recombinant Proteins; D003245:Consensus Statements as Topic
chemical_list: D004921:Erythropoietin; D016179:Granulocyte Colony-Stimulating Factor; D011994:Recombinant Proteins